Details
Stereochemistry | RACEMIC |
Molecular Formula | C21H27NO |
Molecular Weight | 309.4452 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C2=CC=CC=C2
InChI
InChIKey=USSIQXCVUWKGNF-UHFFFAOYSA-N
InChI=1S/C21H27NO/c1-5-20(23)21(16-17(2)22(3)4,18-12-8-6-9-13-18)19-14-10-7-11-15-19/h6-15,17H,5,16H2,1-4H3
Molecular Formula | C21H27NO |
Molecular Weight | 309.4452 |
Charge | 0 |
Count |
|
Stereochemistry | RACEMIC |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Optical Activity | ( + / - ) |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:04:46 UTC 2023
by
admin
on
Fri Dec 15 15:04:46 UTC 2023
|
Record UNII |
UC6VBE7V1Z
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
WHO-ATC |
N07BC02
Created by
admin on Fri Dec 15 15:04:46 UTC 2023 , Edited by admin on Fri Dec 15 15:04:46 UTC 2023
|
||
|
NCI_THESAURUS |
C1506
Created by
admin on Fri Dec 15 15:04:46 UTC 2023 , Edited by admin on Fri Dec 15 15:04:46 UTC 2023
|
||
|
NDF-RT |
N0000175684
Created by
admin on Fri Dec 15 15:04:46 UTC 2023 , Edited by admin on Fri Dec 15 15:04:46 UTC 2023
|
||
|
WHO-ATC |
N02AC52
Created by
admin on Fri Dec 15 15:04:46 UTC 2023 , Edited by admin on Fri Dec 15 15:04:46 UTC 2023
|
||
|
NCI_THESAURUS |
C67413
Created by
admin on Fri Dec 15 15:04:46 UTC 2023 , Edited by admin on Fri Dec 15 15:04:46 UTC 2023
|
||
|
DEA NO. |
9250
Created by
admin on Fri Dec 15 15:04:46 UTC 2023 , Edited by admin on Fri Dec 15 15:04:46 UTC 2023
|
||
|
LIVERTOX |
NBK548084
Created by
admin on Fri Dec 15 15:04:46 UTC 2023 , Edited by admin on Fri Dec 15 15:04:46 UTC 2023
|
||
|
WHO-VATC |
QN07BC02
Created by
admin on Fri Dec 15 15:04:46 UTC 2023 , Edited by admin on Fri Dec 15 15:04:46 UTC 2023
|
||
|
CFR |
21 CFR 862.3620
Created by
admin on Fri Dec 15 15:04:46 UTC 2023 , Edited by admin on Fri Dec 15 15:04:46 UTC 2023
|
||
|
WHO-ESSENTIAL MEDICINES LIST |
24.5
Created by
admin on Fri Dec 15 15:04:46 UTC 2023 , Edited by admin on Fri Dec 15 15:04:46 UTC 2023
|
||
|
WHO-VATC |
QN02AC52
Created by
admin on Fri Dec 15 15:04:46 UTC 2023 , Edited by admin on Fri Dec 15 15:04:46 UTC 2023
|
||
|
NDF-RT |
N0000175690
Created by
admin on Fri Dec 15 15:04:46 UTC 2023 , Edited by admin on Fri Dec 15 15:04:46 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
200-996-9
Created by
admin on Fri Dec 15 15:04:46 UTC 2023 , Edited by admin on Fri Dec 15 15:04:46 UTC 2023
|
PRIMARY | |||
|
6813
Created by
admin on Fri Dec 15 15:04:46 UTC 2023 , Edited by admin on Fri Dec 15 15:04:46 UTC 2023
|
PRIMARY | RxNorm | ||
|
DTXSID7023273
Created by
admin on Fri Dec 15 15:04:46 UTC 2023 , Edited by admin on Fri Dec 15 15:04:46 UTC 2023
|
PRIMARY | |||
|
100000091046
Created by
admin on Fri Dec 15 15:04:46 UTC 2023 , Edited by admin on Fri Dec 15 15:04:46 UTC 2023
|
PRIMARY | |||
|
28017
Created by
admin on Fri Dec 15 15:04:46 UTC 2023 , Edited by admin on Fri Dec 15 15:04:46 UTC 2023
|
PRIMARY | |||
|
m7286
Created by
admin on Fri Dec 15 15:04:46 UTC 2023 , Edited by admin on Fri Dec 15 15:04:46 UTC 2023
|
PRIMARY | Merck Index | ||
|
C62044
Created by
admin on Fri Dec 15 15:04:46 UTC 2023 , Edited by admin on Fri Dec 15 15:04:46 UTC 2023
|
PRIMARY | |||
|
3119
Created by
admin on Fri Dec 15 15:04:46 UTC 2023 , Edited by admin on Fri Dec 15 15:04:46 UTC 2023
|
PRIMARY | |||
|
SUB08833MIG
Created by
admin on Fri Dec 15 15:04:46 UTC 2023 , Edited by admin on Fri Dec 15 15:04:46 UTC 2023
|
PRIMARY | |||
|
DB00333
Created by
admin on Fri Dec 15 15:04:46 UTC 2023 , Edited by admin on Fri Dec 15 15:04:46 UTC 2023
|
PRIMARY | |||
|
167309
Created by
admin on Fri Dec 15 15:04:46 UTC 2023 , Edited by admin on Fri Dec 15 15:04:46 UTC 2023
|
PRIMARY | |||
|
6807
Created by
admin on Fri Dec 15 15:04:46 UTC 2023 , Edited by admin on Fri Dec 15 15:04:46 UTC 2023
|
PRIMARY | |||
|
76-99-3
Created by
admin on Fri Dec 15 15:04:46 UTC 2023 , Edited by admin on Fri Dec 15 15:04:46 UTC 2023
|
PRIMARY | |||
|
4095
Created by
admin on Fri Dec 15 15:04:46 UTC 2023 , Edited by admin on Fri Dec 15 15:04:46 UTC 2023
|
PRIMARY | |||
|
CHEMBL651
Created by
admin on Fri Dec 15 15:04:46 UTC 2023 , Edited by admin on Fri Dec 15 15:04:46 UTC 2023
|
PRIMARY | |||
|
D008691
Created by
admin on Fri Dec 15 15:04:46 UTC 2023 , Edited by admin on Fri Dec 15 15:04:46 UTC 2023
|
PRIMARY | |||
|
788
Created by
admin on Fri Dec 15 15:04:46 UTC 2023 , Edited by admin on Fri Dec 15 15:04:46 UTC 2023
|
PRIMARY | |||
|
UC6VBE7V1Z
Created by
admin on Fri Dec 15 15:04:46 UTC 2023 , Edited by admin on Fri Dec 15 15:04:46 UTC 2023
|
PRIMARY | |||
|
UC6VBE7V1Z
Created by
admin on Fri Dec 15 15:04:46 UTC 2023 , Edited by admin on Fri Dec 15 15:04:46 UTC 2023
|
PRIMARY | |||
|
Methadone
Created by
admin on Fri Dec 15 15:04:46 UTC 2023 , Edited by admin on Fri Dec 15 15:04:46 UTC 2023
|
PRIMARY | |||
|
5458
Created by
admin on Fri Dec 15 15:04:46 UTC 2023 , Edited by admin on Fri Dec 15 15:04:46 UTC 2023
|
PRIMARY | |||
|
1728
Created by
admin on Fri Dec 15 15:04:46 UTC 2023 , Edited by admin on Fri Dec 15 15:04:46 UTC 2023
|
PRIMARY | |||
|
50140
Created by
admin on Fri Dec 15 15:04:46 UTC 2023 , Edited by admin on Fri Dec 15 15:04:46 UTC 2023
|
PRIMARY | |||
|
METHADONE
Created by
admin on Fri Dec 15 15:04:46 UTC 2023 , Edited by admin on Fri Dec 15 15:04:46 UTC 2023
|
PRIMARY | |||
|
297-88-1
Created by
admin on Fri Dec 15 15:04:46 UTC 2023 , Edited by admin on Fri Dec 15 15:04:46 UTC 2023
|
SUPERSEDED |
Related Record | Type | Details | ||
---|---|---|---|---|
|
SALT/SOLVATE -> PARENT | |||
|
METABOLIC ENZYME -> SUBSTRATE | |||
|
METABOLIC ENZYME -> SUBSTRATE | |||
|
METABOLIC ENZYME -> SUBSTRATE |
CYP2C19 preferentially metabolized (R)-methadone,
|
||
|
METABOLIC ENZYME -> SUBSTRATE |
CYP2B6 preferentially metabolized (S)-methadone,
|
||
|
PARENT -> SALT/SOLVATE | |||
|
TARGET->ANTAGONIST | |||
|
BINDER->LIGAND |
BINDING
|
||
|
METABOLIC ENZYME -> SUBSTRATE |
CYP3A4 showed no preference between the two enantiomers
|
||
|
ACTIVE ENANTIOMER->RACEMATE |
approximately 50x the potency of the S-(+)-enantiomer as well as greater μ-opioid receptor selectivity
|
||
|
SALT/SOLVATE -> PARENT |
APPROXIMATE PURE ANHYDROUS DRUG CONTENT (IN PERCENT)
|
||
|
TRANSPORTER -> SUBSTRATE | |||
|
SALT/SOLVATE -> PARENT |
APPROXIMATE PURE ANHYDROUS DRUG CONTENT (IN PERCENT)
|
||
|
TARGET -> INHIBITOR |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLITE INACTIVE -> PARENT |
The hierarchy of EDDPgeneration was CYP2B6 > CYP2C19zCYP3A4
MAJOR
|
||
|
PARENT -> METABOLITE |
MINOR
|
||
|
METABOLITE -> PARENT |
MINOR
|
||
|
METABOLITE -> PARENT |
5-10% of the dose but there is a large individual variation due to pH, urine volume, dose and metabolic rate
MINOR
|
||
|
METABOLITE ACTIVE -> PARENT | |||
|
METABOLITE ACTIVE -> PARENT | |||
|
METABOLITE ACTIVE -> PARENT |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
---|---|---|---|---|---|---|
Biological Half-life | PHARMACOKINETIC |
|
Elimination PHARMACOKINETIC |
|
||